Genetic variation in APOJ, LPL, and TNFRSF10B affects plasma fatty acid distribution in Alaskan Eskimos

American Journal of Clinical Nutrition

Volumn 91, Issue 6, 2010, Pages 1574-1583

  Voruganti, V Saroja ^a   Cole, Shelley A ^a   Ebbesson, Sven O E ^b   Göring, Harald H H ^a   Haack, Karin ^a   Laston, Sandra ^a   Wenger, Charlotte R ^a   Tejero, M Elizabeth ^a   Devereux, Richard B ^c   Fabsitz, Richard R ^d   MacCluer, Jean W ^a   Umans, Jason G ^e   Howard, Barbara V ^e   Comuzzie, Anthony G ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b Norton Sound Health Corporation   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e MEDSTAR RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN; FATTY ACID; LIPOPROTEIN LIPASE; MACROPHAGE SCAVENGER RECEPTOR 1; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; SCAVENGER RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BAYES THEOREM; BODY FAT DISTRIBUTION; CHROMOSOME; CONTROLLED STUDY; ESKIMO; FATTY ACID BLOOD LEVEL; FEMALE; GAS CHROMATOGRAPHY; GENE LOCATION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM;

CARDIOVASCULAR DISEASES; CLUSTERIN; DIABETES MELLITUS, TYPE 2; DNA; FATTY ACIDS, NONESTERIFIED; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INUITS; LIPOPROTEIN LIPASE; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT, HERITABLE; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; SCAVENGER RECEPTORS, CLASS A;

EID: 77953031665     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.2009.28927     Document Type: Article

References (49)

1. Saleh J, Sniderman AD, Cianflone K. Regulation of plasma fatty acid metabolism. Clin Chim Acta 1999;286:163-180 (Pubitemid 29406106)
2. Paolisso G, Manzella D, Rizzo MR, et al. Elevated plasma fatty acid concentrations stimulate the cardiac autonomous nervous system in healthy subjects. Am J Clin Nutr 2000;72:723-730 (Pubitemid 30667093)
3. Tiemeier H, van Tuijil HR, Hoffman A, Kiliaan AJ, Breteler MM. Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am J Clin Nutr 2003;78:40-46
4. Simon JA, Hodgkins ML, Browner WS. Serum fatty acids and the risk of coronary heart disease. Am J Epidemiol 1995;142:469-476
5. Wang L, Folsom AR, Zheng ZJ, Pankow JS, Eckfeldt JH. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) study. Am J Clin Nutr 2003;78:91-98 (Pubitemid 39655252)
6. Tanaka T, Shen J, Abecasis GR, et al. Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI study. PLoS Genet 2009;5:e1000338.
7. Middaugh JP. Cardiovascular deaths among Alaskan Natives, 1980-1986. Am J Public Health 1990;80:282-285
8. Ebbesson SOE, Kennish J, Ebbesson L, Go O, Yeh J. Diabetes is related to fatty acid imbalance in Eskimos. Int J Circumpolar Health 1999;58: 108-119
9. Schumacher C, Davidson M, Ehrsam G. Cardiovascular disease among Alaska Natives: a review of the literature. Int J Circumpolar Health 2003;62:343-362
10. Howard BV, Devereux RB, Cole SA, et al. A genetic and epidemiological study of cardiovascular disease in Alaska Natives (GOCADAN): design and methods. Int J Circumpolar Health 2005;64:206-221
11. Ebbesson SOE, Laston S, Wenger CR, et al. Recruitment and community interactions in the GOCADAN study. Int J Circumpolar Health 2006;65:55-64.
12. Sobel E, Lange K. Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker sharing statistics. Am J Hum Genet 1996;58:1323-1337 (Pubitemid 26153844)
13. Heath SC. Markov chain Monte Carlo segregation and linkage analysis for oligogenic models. Am J Hum Genet 1997;61:748-760 (Pubitemid 27418415)
14. Kong A, Gudbjartsson DF, Sainz J, et al. A high-resolution recombination map of the human genome. Nat Genet 2002;31:241-247
15. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998;62:1198-1211 (Pubitemid 28199022)
16. Hopper JL, Mathews JD. Extensions to multivariate normal models for pedigree analysis. Ann Hum Genet 1982;46:373-383
17. Self S, Liang K. Asymptotic properties of maximum likelihood-ratio tests under nonstandard conditions. J Am Stat Assoc 1987;82:605-610
18. Blangero J, Goring HHH, Kent JW Jr, et al. Quantitative trait nucleotide analysis using bayesian model selection. Hum Biol 2005;77:541-559
19. Boerwinkle E, Chakraborty R, Sing CF. The use of measured genotype information in the analysis of quantitative phenotypes in man. I. Models and analytical methods. Ann Hum Genet 1986;50:181-194
20. Neale BM, Sham PC. The future of association studies: gene-based analysis and replication. Am J Hum Genet 2004;75:353-362 (Pubitemid 39095812)
21. Charlesworth JC, Peralta JM, Drigalenko E, et al. Toward the identifi- cation of causal genes in complex diseases: a gene-centric joint test of significance combining genomic and transcriptomic data. BMC Proc 2009;3:S92
22. Moskvina V, Schmidt KM. Individual SNP allele reconstruction from informative markers selected by a non-linear Gauss-type algorithm. Hum Hered 2006;62:97-106. (Pubitemid 44689375)
23. Kass RE, Raftery AE. Bayes factors. J Am Stat Assoc 1995;90:773-795
24. Zhou YE, Egeland GM, Meltzer SJ, Kubow S. The association of desaturase 9 and plasma fatty acid composition with insulin resistance-associated factors in female adolescents. Metabolism 2009;58:158-166
25. Taylor MRG. Pharmacogenetics of the human beta-adrenergic receptors. Pharmacogenomics J 2007;7:29-37.
26. Mitchell BD, Blangero J, Comuzzie AG, et al. A paired sibling analysis of the beta-3 adrenergic receptor and obesity in Mexican Americans. J Clin Invest 1998;101:584-587
27. Corella D, Guillén M, Portolés O, et al. Gender specific associations of the Trp64Arg mutation in the beta3-adrenergic receptor gene with obesity-related phenotypes in a Mediterranean population: interaction with a common lipoprotein lipase gene variation. J Intern Med 2001; 250:348-360
28. Jemaa R, Tuzet S, Portos C, Betoulle D, Apfelbaum M, Fumeron F. Lipoprotein lipase gene polymorphisms: associations with hypertriglyceridemia and body mass index in obese people. Int J Obes Relat Metab Disord 1995;19:270-274
29. Mattei MG, Etienne J, Chuat JC, et al. Assignment of the human lipoprotein lipase (LPL) gene to chromosome band 8p22. Cytogenet Cell Genet 1993;63:45-46
30. Hu Y, LiuW, Huang R, Zhang X. A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases. J Lipid Res 2006;47:1908-1914
31. Sagoo GS, Tatt I, Salanti G, et al. Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis. Am J Epidemiol 2008;168:1233-1246
32. Clee SM, Loubser O, Collins J, Kastelein JJ, Hayden MR. The LPL S447X cSNP is associated with decreased blood pressure and plasma triglycerides, and reduced risk of coronary artery disease. Clin Genet 2001;60:293-300.
33. Rizzi F, Bettuzzi S. The clusterin paradigm in prostate and breast carciongenesis. Endocr Relat Cancer 2010;17:R1-17.
34. Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 2009;41:1088-1093
35. Lambert JC, Heath S, Even G, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009;41:1094-1099
36. Poulakou MV, Paraskevas KI,Wilson MR, et al. Apolipoprotein J and leptin levels in patients with coronary heart disease. In Vivo 2008;22:537-542
37. Nestlerode CS, Bunker CH, Sanghera DK, Aston CE, Ukoli FA, Kamboh MI. Apolipoprotein J polymorphisms and serum HDL cholesterol levels in African blacks. Hum Biol 1999;71:197-218.
38. Walczak H, Degli-Eposti MA, Johnson RA, et al. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J 1997;16:5386-5397
39. Malhi H, Barreyro FJ, Isomoto H, Brank SF, Gores GJ. Free fatty acids sensitize hepatocytes to TRAIL mediated cytotoxicity. Gut 2007;56: 1124-1131 (Pubitemid 47123245)
40. Fischer-Posovszky P, Tornqvist H, Klaus-Michael D, Wabitsch M. Inhibition of death-receptor mediated apoptosis in human adipocytes by the insulin-like growth factor-1 (IGF-1)/IGF-1 receptor autocrine circuit. Endocinology 2004;145:1849-1859.
41. Kavurma MM, Bennett MR. Expression, regulation and function of trail in atherosclerosis. Biochem Pharmacol 2008;75:1441-1450
42. Choi JW, Song JS, Pai SH. Associations of serum TRAIL concentrations, anthropometric variables and serum lipid parameters in healthy adults. Ann Clin Lab Sci 2004;34:400-404
43. Teng MS, Brandwein-Gensler MS, Teixeira MS, Martignettie JA, Duffey DC. A study of TRAIL receptors in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2005;131:407-412
44. Emi M, Asaoka H, Matsumoto A, et al. Structure, organization, and chromosomal mapping of the human macrophage scavenger receptor gene. J Biol Chem 1993;268:2120-2125
45. Bobryshev YV. Monocyte recruitment and foam cell formation on atherosclerosis. Micron 2006;37:208-222 (Pubitemid 43106595)
46. Kathiresan S, Manning AK, Demissie S, et al. A genome-wise association study for blood lipid phenotypes in the Framingham Heart study. BMC Med Genet 2007;8:S17.
47. Willer CJ, Sanna S, Jackson AU, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008;40:161-169
48. Chasman DI, Pare G,Mora S, et al. Forty-three loci associated with plasma lipoprotein size, concentration and cholesterol content in genome-wide analysis. PLoS Genet 2009;5:e100730.
49. Lanktree MB, Anand SS, Yusuf S, Hegele RA, SHARE investigators. Replication of genetic associations with plasma lipoprotein traits in a multiethnic sample. J Lipid Res 2009;50:1487-1496